TGEX-FC-hG1-Zeo

MX025

Price (USD): $689.00
+

TGEX-FC-hG1-Zeo

Cloning Vector for the Mammalian Expression of Human IgG1 Fc Fusion Molecules

Technical Description

TGEX™-FC-hG1-Zeo is designed for the expression of N-terminal fusions with the Fc region of human IgG1. Using transient transfection technologies yields of fusion molecules between 20 mg/L and 200 mg/L and more in serum-free conditions can be obtained in just a few days.

Applications

  • Mammalian expression of N-terminal Fc fusion molecules by transient gene expression.

  • Selection of stable transfectants using Zeocin™.

For research use only; not intended for any animal or human therapeutic or diagnostic use.

Specifications

General Characteristics:

Plasmid Size: 5519
Promoter: CMV + TPL
Leader Peptide: pelBK
Cloning Site: Double BsaI
Fusion Protein: human IgG1 Fc region
Selection: ampicillin (bacteria), zeocin™ (mammalian)
Replication: pMB1 high copy number

Physical Characteristics:

Concentration: 0.5 µg/µl.
Product Size: 10 µg.
Buffer: DNA Conservation Buffer (Tris/HCL 5 mM, EDTA 0.1 mM, pH 8.5, sterile).
Storage Temperature: -20°C.

Quality Control & Certification of Analysis

Product Sequence:

The entire plasmid sequence was confirmed by the Sanger method.

Certification:

Product meets all specifications.

TEGX-FC-hG1-Zeo map

 

TEGX-FC-hG1-Zeo cloning site

 

Citations

  1. Mendoza-Salazar I., Gómez-Castellano KM., González-González E., Gamboa-Suasnavart R., Rodríguez-Luna SD., Santiago-Casas G., Cortés-Paniagua MI., Pérez-Tapia SM., Almagro JC. (2022). Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library. Antibodies (Basel),10;11(1):13.

  2. Pedraza-Escalona M., Guzmán-Bringas O., Arrieta-Oliva HI., Gómez-Castellano K., Salinas-Trujano J., Torres-Flores J., Muñoz-Herrera JC., Camacho-Sandoval R., Contreras-Pineda P., Chacón-Salinas R., Pérez-Tapia SM, Almagro JC. (2021). Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. BMC Infect Dis.,30;21(1):1121.

  3. Mukherjee A., Stathos ME., Varner C., Arsiwala A., Frey S., Hu Y., Smalley DM., Schaffer DV., Kane RS. (2020). One-pot synthesis of heterodimeric agonists that activate the canonical Wnt signaling pathway. Chem. Commun. (Camb) 56(25):3685-3688.